Israel Chemicals (NYSE:ICL) Posts Earnings Results, Beats Estimates By $0.01 EPS

Israel Chemicals (NYSE:ICL) released its quarterly earnings data on Wednesday. The basic materials company reported $0.12 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.01, Briefing.com reports. Israel Chemicals had a return on equity of 14.14% and a net margin of 9.04%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the business posted $0.09 EPS. The business’s revenue for the quarter was up 3.9% on a year-over-year basis.

NYSE:ICL traded up $0.06 during mid-day trading on Friday, reaching $5.41. 95,354 shares of the stock were exchanged, compared to its average volume of 120,618. The company has a 50 day moving average of $5.20. The firm has a market capitalization of $7.05 billion, a PE ratio of 14.62, a P/E/G ratio of 1.35 and a beta of 0.83. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.43 and a quick ratio of 0.79. Israel Chemicals has a 1 year low of $4.92 and a 1 year high of $6.90.

A number of research analysts have recently commented on the company. ValuEngine downgraded Israel Chemicals from a “buy” rating to a “hold” rating in a report on Saturday, June 1st. Zacks Investment Research upgraded Israel Chemicals from a “hold” rating to a “strong-buy” rating and set a $6.00 price objective on the stock in a report on Friday, June 7th. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $5.94.

A number of large investors have recently added to or reduced their stakes in the stock. Signaturefd LLC lifted its position in Israel Chemicals by 30.1% during the 2nd quarter. Signaturefd LLC now owns 13,119 shares of the basic materials company’s stock worth $68,000 after acquiring an additional 3,038 shares during the period. First Trust Advisors LP acquired a new stake in Israel Chemicals during the 1st quarter worth approximately $73,000. Wetherby Asset Management Inc. lifted its position in Israel Chemicals by 49.9% during the 2nd quarter. Wetherby Asset Management Inc. now owns 18,566 shares of the basic materials company’s stock worth $97,000 after acquiring an additional 6,182 shares during the period. Quadrant Capital Group LLC lifted its position in Israel Chemicals by 62.4% during the 1st quarter. Quadrant Capital Group LLC now owns 25,143 shares of the basic materials company’s stock worth $130,000 after acquiring an additional 9,664 shares during the period. Finally, Ballentine Partners LLC lifted its position in Israel Chemicals by 20.5% during the 2nd quarter. Ballentine Partners LLC now owns 26,747 shares of the basic materials company’s stock worth $139,000 after acquiring an additional 4,546 shares during the period. Hedge funds and other institutional investors own 8.06% of the company’s stock.

About Israel Chemicals

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.

Recommended Story: Leveraged Buyout (LBO)

Earnings History for Israel Chemicals (NYSE:ICL)

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.